These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 22052158)

  • 1. Further evaluation of quantum chemical methods for the prediction of non-specific binding of positron emission tomography tracers.
    Dickson CJ; Gee AD; Bennacef I; Gould IR; Rosso L
    Phys Chem Chem Phys; 2011 Dec; 13(48):21552-7. PubMed ID: 22052158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ab initio computational study of positron emission tomography ligands interacting with lipid molecule for the prediction of nonspecific binding.
    Rosso L; Gee AD; Gould IR
    J Comput Chem; 2008 Nov; 29(14):2397-405. PubMed ID: 18442082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular tracers for the PET and SPECT imaging of disease.
    Pimlott SL; Sutherland A
    Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward [18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice.
    Ting R; Harwig C; auf dem Keller U; McCormick S; Austin P; Overall CM; Adam MJ; Ruth TJ; Perrin DM
    J Am Chem Soc; 2008 Sep; 130(36):12045-55. PubMed ID: 18700764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approximations to complete basis set-extrapolated, highly correlated non-covalent interaction energies.
    Mackie ID; DiLabio GA
    J Chem Phys; 2011 Oct; 135(13):134318. PubMed ID: 21992316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics.
    Morris ED; Yoder KK
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):606-17. PubMed ID: 16788713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmaceutical chemistry for positron emission tomography.
    Li Z; Conti PS
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decay data and production yields of some non-standard positron emitters used in PET.
    Qaim SM
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):111-20. PubMed ID: 18174879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
    Logan J; Ding YS; Lin KS; Pareto D; Fowler J; Biegon A
    Nucl Med Biol; 2005 Jul; 32(5):531-42. PubMed ID: 15982584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional positron emission tomography imaging with 124I and 86Y.
    Vandenberghe S
    Nucl Med Commun; 2006 Mar; 27(3):237-45. PubMed ID: 16479243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction path potential for complex systems derived from combined ab initio quantum mechanical and molecular mechanical calculations.
    Lu Z; Yang W
    J Chem Phys; 2004 Jul; 121(1):89-100. PubMed ID: 15260525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotracers for positron emission tomography imaging.
    Fowler JS; Ding YS; Volkow ND
    Semin Nucl Med; 2003 Jan; 33(1):14-27. PubMed ID: 12605354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of carbon-11 PET radiotracers from unlabeled precursors by preparative HPLC and SPE.
    Zheng QH; Mock BH
    Biomed Chromatogr; 2005 Nov; 19(9):671-6. PubMed ID: 15803445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 and radiopharmaceutical metabolism.
    Giron MC; Portolan S; Bin A; Mazzi U; Cutler CS
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):254-66. PubMed ID: 18475251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image quality with non-standard nuclides in PET.
    Laforest R; Liu X
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):151-8. PubMed ID: 18043539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.
    Beer AJ; Grosu AL; Carlsen J; Kolk A; Sarbia M; Stangier I; Watzlowik P; Wester HJ; Haubner R; Schwaiger M
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6610-6. PubMed ID: 18006761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.
    Mazière B; Delforge J
    Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of radiotracers in human plasma during positron emission tomography.
    Cumming P; Yokoi F; Chen A; Deep P; Dagher A; Reutens D; Kapczinski F; Wong DF; Gjedde A
    Synapse; 1999 Nov; 34(2):124-34. PubMed ID: 10502311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.